Evidence map›Paper›PMID 31804341›Full record

SynthesisMedicine2019

Management of delayed encephalopathy after CO poisoning: An evidence-based narrative review.

Xiao-Min Xu, Hua Luo, Ben-Bing Rong, Xiao-Mei Zheng, Feng-Tao Wang, Shu-Jiang Zhang, Zuo-Xiao Li

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 4 countries.

Xiao-Min XuDepartment of Neurology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Hua Luo
Ben-Bing Rong
Xiao-Mei Zheng
Feng-Tao Wang
Shu-Jiang Zhang
Zuo-Xiao Li
Apple (Israel) · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundApproximately 10% to 30% patients develop delayed encephalopathy after acute CO poisoning (DEACMP). No specific treatment is available and poor prognosis is a characteristic of this disease. We aimed to evaluate the efficacy and safety of all therapies that have been tried in randomized controlled trial (RCT) for DEACMP.

methodsWe conducted a systematic search of the Cochrane, Embase, PubMed, and Web of Science databases.

resultsOverall, 4 RCTs were identified in our study. Both hyperbaric oxygen (HBO) and mesenchymal stem cell (MSC) transplantation were effective in DEACMP, and MSC seemed to be superior to HBO. The addition of dexamethasone, N-butylphthalide, or XingZhi-YiNao granules into HBO, or butylphthalide into MSC could achieve better neurological recovery in DEACMP patients but did not significantly increase the incidence of adverse events.

conclusionSeveral therapies have shown positive results in treating DEACMP and need to be proven by further studies.

Indexed as

BenzofuransBrain DiseasesCarbon Monoxide PoisoningDexamethasoneDrugs, Chinese HerbalHumansHyperbaric OxygenationMesenchymal Stem Cell TransplantationRandomized Controlled Trials as TopicTime Factors3-n-butylphthalideBenzofuransDexamethasoneDrugs, Chinese Herbal

Identifiers

PMID31804341
PMCPMC6919536
OpenAlexW2991917678

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.